{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:53:07Z","timestamp":1780879987254,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12264-019-00424-2","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T13:52:20Z","timestamp":1567518740000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["L-type Calcium Channels are Involved in Iron-induced Neurotoxicity in Primary Cultured Ventral Mesencephalon Neurons of Rats"],"prefix":"10.1007","volume":"36","author":[{"given":"Yu-Yu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Gang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"424_CR1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10534-018-0126-2","volume":"31","author":"A Carocci","year":"2018","unstructured":"Carocci A, Catalano A, Sinicropi MS, Genchi G. Oxidative stress and neurodegeneration: the involvement of iron. Biometals 2018, 31: 715\u2013735.","journal-title":"Biometals"},{"key":"424_CR2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tins.2009.01.006","volume":"32","author":"CS Chan","year":"2009","unstructured":"Chan CS, Gertler TS, Surmeier DJ. Calcium homeostasis, selective vulnerability and Parkinson\u2019s disease. Trends Neurosci 2009, 32: 249\u2013256.","journal-title":"Trends Neurosci"},{"key":"424_CR3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s11064-015-1628-8","volume":"40","author":"C Ju","year":"2015","unstructured":"Ju C, Hou L, Sun F, Zhang L, Zhang Z, Gao H, et al. Anti-oxidation and antiapoptotic effects of chondroitin sulfate on 6-Hydroxydopamine-induced injury through the up-regulation of Nrf2 and inhibition of mitochondria-mediated pathway. Neurochem Res 2015, 40: 1509\u20131519.","journal-title":"Neurochem Res"},{"key":"424_CR4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00702-017-1819-3","volume":"125","author":"Q Liu","year":"2018","unstructured":"Liu Q, Xu Y, Wan W, Ma Z. An unexpected improvement in spatial learning and memory ability in alpha-synuclein A53T transgenic mice. J Neural Transm (Vienna) 2018, 125: 203\u2013210.","journal-title":"J Neural Transm (Vienna)"},{"key":"424_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","volume":"56","author":"KS McNaught","year":"2004","unstructured":"McNaught KS, Perl DP, Brownell AL, Olanow CW. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson\u2019s disease. Ann Neurol 2004, 56: 149\u2013162.","journal-title":"Ann Neurol"},{"key":"424_CR6","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/ejn.13323","volume":"44","author":"Y Xue","year":"2016","unstructured":"Xue Y, Yang YT, Liu HY, Chen WF, Chen AQ, Sheng Q, et al. Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats. Eur J Neurosci 2016, 44: 2247\u20132257.","journal-title":"Eur J Neurosci"},{"key":"424_CR7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/mds.21020","volume":"21","author":"D Berg","year":"2006","unstructured":"Berg D, Hochstrasser H. Iron metabolism in Parkinsonian syndromes. Mov Disord 2006, 21: 1299\u20131310.","journal-title":"Mov Disord"},{"key":"424_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12264-017-0138-x","volume":"33","author":"X Guan","year":"2017","unstructured":"Guan X, Xu X, Zhang M. Region-specific iron measured by MRI as a biomarker for Parkinson\u2019s disease. Neurosci Bull 2017, 33: 561\u2013567.","journal-title":"Neurosci Bull"},{"key":"424_CR9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12264-018-0209-7","volume":"34","author":"N Song","year":"2018","unstructured":"Song N, Xie J. Iron, dopamine, and alpha-synuclein interactions in at-risk dopaminergic neurons in Parkinson\u2019s disease. Neurosci Bull 2018, 34: 382\u2013384.","journal-title":"Neurosci Bull"},{"key":"424_CR10","doi-asserted-by":"crossref","first-page":"47284","DOI":"10.18632\/oncotarget.17618","volume":"8","author":"QM Wang","year":"2017","unstructured":"Wang QM, Xu YY, Liu S, Ma ZG. Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice. Oncotarget 2017, 8: 47284\u201347295.","journal-title":"Oncotarget"},{"key":"424_CR11","doi-asserted-by":"crossref","unstructured":"Greminger AR, Mayer-Proschel M. Identifying the threshold of iron deficiency in the central nervous system of the rat by the auditory brainstem response. ASN Neuro 2015, 7.","DOI":"10.1177\/1759091415569911"},{"key":"424_CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/15216540701222906","volume":"59","author":"C Hidalgo","year":"2007","unstructured":"Hidalgo C, Nunez MT. Calcium, iron and neuronal function. IUBMB Life 2007, 59: 280\u2013285.","journal-title":"IUBMB Life"},{"key":"424_CR13","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1074\/jbc.M806235200","volume":"284","author":"X Gao","year":"2009","unstructured":"Gao X, Campian JL, Qian M, Sun XF, Eaton JW. Mitochondrial DNA damage in iron overload. J Biol Chem 2009, 284: 4767\u20134775.","journal-title":"J Biol Chem"},{"issue":"Suppl 2","key":"424_CR14","doi-asserted-by":"crossref","first-page":"S551","DOI":"10.3233\/JAD-2010-100354","volume":"20","author":"MP Horowitz","year":"2010","unstructured":"Horowitz MP, Greenamyre JT. Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis 2010, 20 Suppl 2: S551\u2013S568.","journal-title":"J Alzheimers Dis"},{"key":"424_CR15","first-page":"515","volume":"8","author":"J Kristinsson","year":"2012","unstructured":"Kristinsson J, Snaedal J, Torsdottir G, Johannesson T. Ceruloplasmin and iron in Alzheimer\u2019s disease and Parkinson\u2019s disease: a synopsis of recent studies. Neuropsychiatr Dis Treat 2012, 8: 515\u2013521.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"424_CR16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","volume":"70","author":"WR Martin","year":"2008","unstructured":"Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008, 70: 1411\u20131417.","journal-title":"Neurology"},{"key":"424_CR17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","volume":"447","author":"CS Chan","year":"2007","unstructured":"Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, et al. \u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease. Nature 2007, 447: 1081\u20131086.","journal-title":"Nature"},{"key":"424_CR18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","volume":"43","author":"E Ilijic","year":"2011","unstructured":"Ilijic E, Guzman JN, Surmeier DJ. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease. Neurobiol Dis 2011, 43: 364\u2013371.","journal-title":"Neurobiol Dis"},{"key":"424_CR19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00001756-199503000-00009","volume":"6","author":"A Kupsch","year":"1995","unstructured":"Kupsch A, Gerlach M, Pupeter SC, Sautter J, Dirr A, Arnold G, et al. Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice. Neuroreport 1995, 6: 621\u2013625.","journal-title":"Neuroreport"},{"key":"424_CR20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ceca.2009.12.003","volume":"47","author":"DJ Surmeier","year":"2010","unstructured":"Surmeier DJ, Guzman JN, Sanchez-Padilla J. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson\u2019s disease. Cell Calcium 2010, 47: 175\u2013182.","journal-title":"Cell Calcium"},{"key":"424_CR21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00441-014-1936-3","volume":"357","author":"SM Berger","year":"2014","unstructured":"Berger SM, Bartsch D. The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function. Cell Tissue Res 2014, 357: 463\u2013476.","journal-title":"Cell Tissue Res"},{"key":"424_CR22","doi-asserted-by":"crossref","first-page":"e98961","DOI":"10.1371\/journal.pone.0098961","volume":"9","author":"YC Lee","year":"2014","unstructured":"Lee YC, Lin CH, Wu RM, Lin JW, Chang CH, Lai MS. Antihypertensive agents and risk of Parkinson\u2019s disease: a nationwide cohort study. PLoS One 2014, 9: e98961.","journal-title":"PLoS One"},{"key":"424_CR23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","volume":"9","author":"GY Oudit","year":"2003","unstructured":"Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, et al. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003, 9: 1187\u20131194.","journal-title":"Nat Med"},{"key":"424_CR24","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s11064-007-9313-1","volume":"32","author":"JA Gaasch","year":"2007","unstructured":"Gaasch JA, Geldenhuys WJ, Lockman PR, Allen DD, Van der Schyf CJ. Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem Res 2007, 32: 1686\u20131693.","journal-title":"Neurochem Res"},{"key":"424_CR25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12640-012-9309-8","volume":"22","author":"Z Ma","year":"2012","unstructured":"Ma Z, Zhou Y, Xie J. Nifedipine prevents iron accumulation and reverses iron-overload-induced dopamine neuron degeneration in the substantia nigra of rats. Neurotox Res 2012, 22: 274\u2013279.","journal-title":"Neurotox Res"},{"key":"424_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tox.2016.07.022","volume":"365","author":"DG Lee","year":"2016","unstructured":"Lee DG, Park J, Lee HS, Lee SR, Lee DS. Iron overload-induced calcium signals modulate mitochondrial fragmentation in HT-22 hippocampal neuron cells. Toxicology 2016, 365: 17\u201324.","journal-title":"Toxicology"},{"key":"424_CR27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","volume":"81","author":"KS McNaught","year":"2002","unstructured":"McNaught KS, Mytilineou C, Jnobaptiste R, Yabut J, Shashidharan P, Jennert P, et al. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 2002, 81: 301\u2013306.","journal-title":"J Neurochem"},{"key":"424_CR28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1385-299X(96)00020-7","volume":"1","author":"B Pardo","year":"1997","unstructured":"Pardo B, Paino CL, Casarejos MJ, Mena MA. Neuronal-enriched cultures from embryonic rat ventral mesencephalon for pharmacological studies of dopamine neurons. Brain Res Brain Res Protoc 1997, 1: 127\u2013132.","journal-title":"Brain Res Brain Res Protoc"},{"key":"424_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2007.02.018","volume":"256","author":"T Sanelli","year":"2007","unstructured":"Sanelli T, Ge W, Leystra-Lantz C, Strong MJ. Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant. J Neurol Sci 2007, 256: 39\u201351.","journal-title":"J Neurol Sci"},{"key":"424_CR30","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2007.11.025","volume":"30","author":"S Zhang","year":"2009","unstructured":"Zhang S, Wang J, Song N, Xie J, Jiang H. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Neurobiol Aging 2009, 30: 1466\u20131476.","journal-title":"Neurobiol Aging"},{"key":"424_CR31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.chembiol.2006.08.005","volume":"13","author":"HA Wetli","year":"2006","unstructured":"Wetli HA, Buckett PD, Wessling-Resnick M. Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake. Chem Biol 2006, 13: 965\u2013972.","journal-title":"Chem Biol"},{"key":"424_CR32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/cr.2010.20","volume":"20","author":"H Jiang","year":"2010","unstructured":"Jiang H, Song N, Xu H, Zhang S, Wang J, Xie J. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE\/IRP dependent. Cell Res 2010, 20: 345\u2013356.","journal-title":"Cell Res"},{"key":"424_CR33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1196\/annals.1306.025","volume":"1012","author":"MB Youdim","year":"2004","unstructured":"Youdim MB, Stephenson G, Ben Shachar D. Ironing iron out in Parkinson\u2019s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann N Y Acad Sci 2004, 1012: 306\u2013325.","journal-title":"Ann N Y Acad Sci"},{"key":"424_CR34","first-page":"13","volume":"35","author":"JN Umbreit","year":"1998","unstructured":"Umbreit JN, Conrad ME, Moore EG, Latour LF. Iron absorption and cellular transport: the mobilferrin\/paraferritin paradigm. Semin Hematol 1998, 35: 13\u201326.","journal-title":"Semin Hematol"},{"key":"424_CR35","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuint.2007.10.019","volume":"52","author":"HM Xu","year":"2008","unstructured":"Xu HM, Jiang H, Wang J, Luo B, Xie JX. Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells. Neurochem Int 2008, 52: 1044\u20131051.","journal-title":"Neurochem Int"},{"key":"424_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0006-8993(95)00629-5","volume":"691","author":"BA Faucheux","year":"1995","unstructured":"Faucheux BA, Herrero MT, Villares J, Levy R, Javoy-Agid F, Obeso JA, et al. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson\u2019s disease and MPTP-lesioned monkeys. Brain Res 1995, 691: 115\u2013124.","journal-title":"Brain Res"},{"key":"424_CR37","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/jnr.21430","volume":"85","author":"N Song","year":"2007","unstructured":"Song N, Jiang H, Wang J, Xie JX. Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. J Neurosci Res 2007, 85: 3118\u20133126.","journal-title":"J Neurosci Res"},{"key":"424_CR38","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3109\/00207454.2013.813510","volume":"123","author":"MO Bostanci","year":"2013","unstructured":"Bostanci MO, Bagirici F. Blocking of L-type calcium channels protects hippocampal and nigral neurons against iron neurotoxicity. The role of L-type calcium channels in iron-induced neurotoxicity. Int J Neurosci 2013, 123: 876\u2013882.","journal-title":"Int J Neurosci"},{"key":"424_CR39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11064-011-0591-2","volume":"37","author":"JA Lockman","year":"2012","unstructured":"Lockman JA, Geldenhuys WJ, Bohn KA, Desilva SF, Allen DD, Van der Schyf CJ. Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types. Neurochem Res 2012, 37: 134\u2013142.","journal-title":"Neurochem Res"},{"key":"424_CR40","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","volume":"84","author":"RG Tsushima","year":"1999","unstructured":"Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP, Backx PH. Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ Res 1999, 84: 1302\u20131309.","journal-title":"Circ Res"},{"key":"424_CR41","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1172\/JCI95898","volume":"128","author":"JN Guzman","year":"2018","unstructured":"Guzman JN, Ilijic E, Yang B, Sanchez-Padilla J, Wokosin D, Galtieri D, et al. Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress. J Clin Invest 2018, 128: 2266\u20132280.","journal-title":"J Clin Invest"},{"key":"424_CR42","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1523\/JNEUROSCI.2519-09.2009","volume":"29","author":"JN Guzman","year":"2009","unstructured":"Guzman JN, Sanchez-Padilla J, Chan CS, Surmeier DJ. Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci 2009, 29: 11011\u201311019.","journal-title":"J Neurosci"},{"key":"424_CR43","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1253\/circj.CJ-12-1516","volume":"77","author":"H Lin","year":"2013","unstructured":"Lin H, Li HF, Lian WS, Chen HH, Lan YF, Lai PF, et al. Thromboxane A2 mediates iron-overload cardiomyopathy in mice through calcineurin-nuclear factor of activated T cells signaling pathway. Circ J 2013, 77: 2586\u20132595.","journal-title":"Circ J"},{"key":"424_CR44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1474-9726.2010.00652.x","volume":"10","author":"I Pelizzoni","year":"2011","unstructured":"Pelizzoni I, Macco R, Morini MF, Zacchetti D, Grohovaz F, Codazzi F. Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity. Aging Cell 2011, 10: 172\u2013183.","journal-title":"Aging Cell"},{"key":"424_CR45","first-page":"13","volume":"7","author":"CD Sanmartin","year":"2014","unstructured":"Sanmartin CD, Paula-Lima AC, Garcia A, Barattini P, Hartel S, Nunez MT, et al. Ryanodine receptor-mediated Ca(2+) release underlies iron-induced mitochondrial fission and stimulates mitochondrial Ca(2+) uptake in primary hippocampal neurons. Front Mol Neurosci 2014, 7: 13.","journal-title":"Front Mol Neurosci"},{"key":"424_CR46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardiores.2006.02.019","volume":"71","author":"AV Zima","year":"2006","unstructured":"Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006, 71: 310\u2013321.","journal-title":"Cardiovasc Res"},{"key":"424_CR47","doi-asserted-by":"crossref","first-page":"13382","DOI":"10.1074\/jbc.M110.213785","volume":"286","author":"P Munoz","year":"2011","unstructured":"Munoz P, Humeres A, Elgueta C, Kirkwood A, Hidalgo C, Nunez MT. Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity. J Biol Chem 2011, 286: 13382\u201313392.","journal-title":"J Biol Chem"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00424-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-019-00424-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00424-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:38:38Z","timestamp":1599003518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-019-00424-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1007\/s12264-019-00424-2","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"31 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}